Mesentech

11 employees

Mesentech is a company focused on treating diseases and medical conditions that relate to bone.

Basic info

Industry

biotechnology research

Sectors

Biotechnology

regenerative medicine

fracture healing

orphan disease

osteoporosis

biomaterials

implants

brittle bone disease

Health Care

osteogenesis imperfecta

Duchenne

Therapeutics

bone-graft

bone-loss

bone

drug conjugate

Medical

Date founded

2016

Funding rounds raised

Mesentech raised undisclosed on January 1, 2022

Investors: Valhalla Angels, a Valhalla Private Capital Company and Red Thread Ventures

Mesentech raised undisclosed on February 1, 2021

Investors: Newton Fund, Propel(x) and Boutique Venture

Mesentech raised undisclosed on November 10, 2020

Investors: Charles Hood Foundation

Mesentech raised undisclosed on May 24, 2019

Investors: E-Fund

Mesentech raised undisclosed on November 1, 2018

Investors: Réseaux de centres d'excellence, Ontario Public Service, CCRM and Federal Economic Development Agency for Southern Ontario | Agence fédérale de ...

Mesentech raised undisclosed on January 1, 2018

Investors: Accel-Rx - Canada's Health Science Accelerator

Mesentech raised undisclosed on October 8, 2017

Investors: Creative Destruction Lab